Health-Related Quality of Life in Mitochondrial Disease Associated with Seizures: A Systematic Literature Review

Author(s)

Bartlett C1, Gregg E2, Arber M2, Graziadio S2, Buesch K3
1York Health Economics Consortium, York, NYK, UK, 2York Health Economics Consortium, York, UK, 3PTC Therapeutics Switzerland GmbH, Steinhausen, Switzerland

OBJECTIVES: Mitochondrial diseases are a diverse group of rare disorders which cause deficiencies in mitochondrial function. Seizures affects between 35% and 60% of those diagnosed. These diseases can have a negative impact on patients’ health-related quality of life (HRQoL). This study was undertaken to review evidence on HRQoL, including utilities, in this population.

METHODS: 14 bibliographic databases and information sources were searched in August 2021 to identify studies reporting HRQoL and utilities. Two reviewers independently assessed the records against the eligibility criteria reported in the review protocol. One reviewer extracted data from the eligible studies and a second checked each data point.

RESULTS: Searches identified 1,181 unique records. Four studies reporting HRQoL data were eligible. All studies elicited data from patients, but one study also used data from mothers. Two studies were in children, one in patients aged <16 years, and one in adults. No utility data were available. Data were reported for the Japanese Mitochondrial Disease Rating Scale (range: 65 to 70, maximum score 80), the Newcastle Mitochondrial Disease Adult Scale (range: 108 to 141, maximum score 145), and the Newcastle Paediatric Mitochondrial Disease Scale (range: 6 to 53, maximum score 107). One study reported mean scores for total behavioural problems (67±17, maximum score 100; Korean Child Behaviour Check List), total parenting stress (94±10, maximum score 100; Korean version of the Parenting Stress Index), and maternal depression (15±9, maximum score 63; Beck Depression Inventory). For all the HRQoL data reported, higher scores indicated more severe disease.

CONCLUSIONS: This is a novel review of HRQoL and utilities in mitochondrial diseases associated with seizures. The evidence is limited; HRQoL data are reported using different tools, limiting the comparability of results. Nevertheless, the results highlight the burden associated with mitochondrial disease with seizures: patients reported severe disease and parents a high level of stress.

Conference/Value in Health Info

2022-05, ISPOR 2022, Washington, DC, USA

Value in Health, Volume 25, Issue 6, S1 (June 2022)

Code

PCR82

Topic

Patient-Centered Research, Study Approaches

Topic Subcategory

Literature Review & Synthesis, Patient-reported Outcomes & Quality of Life Outcomes

Disease

Rare and Orphan Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×